VivoSeq
Other

ARB

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

ARB is an early-stage landscape with 0 programs across 1 company. The most active players are RVL Pharmaceuticals, Inc..

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

29/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

R

RVL Pharmaceuticals, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed4 · 57%
Recruiting1 · 14%
Terminated1 · 14%
Withdrawn1 · 14%

Clinical Trials

Trial Activity

7 trials

Factors Associated With Hospitalization and Severity of Arbovirosis in the Indian Ocean
Recruiting·—·N/A·NCT07119086·200 enrolled
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
Completed·VVanderbilt University Medical Center·Phase 4·NCT04113109·46 enrolled
Intracoronary Darbepoetin-alpha to Reduce The Infarct Size and Post-Infarct Remodeling
Completed·SSeoul National University Bundang Hospital·Phase 2·NCT01538771·80 enrolled
High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy
Completed·OOttawa Hospital Research Institute·N/A·NCT00212901·30 enrolled
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
Completed·YYale University·Phase 4·NCT04649229·46 enrolled
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
Terminated·VVanderbilt University Medical Center·Phase 4·NCT03738878·4 enrolled
To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS
Withdrawn·RRVL Pharmaceuticals, Inc.·Phase 3·NCT02869425

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)